[128] In contrast, other DAT inhibitors such as bupropion haven't been observed to show this effect.[129] These observations have prompted the hypothesis that methylphenidate might work as a "DAT inverse agonist" or "damaging allosteric modifier of the DAT" by reversing the direction with the dopamine efflux with the DAT at larger dosages.[130]Repo